Molecular cloning and expression of human caldecrin
- PMID: 8635596
- DOI: 10.1016/0014-5793(96)00377-8
Molecular cloning and expression of human caldecrin
Abstract
Earlier we reported the primary structure of serum calcium-decreasing factor (caldecrin) from rat pancreas, a protein which is considered to be a member of the elastase family. In this report, we describe the isolation of the two homologous cDNA clones encoding caldecrin from human pancreas, the structures of which are identical except for one base and the corresponding amino acid residue. These human caldecrin isoforms are composed of a signal peptide of 16 amino acids, a propeptide of 13 amino acids, and a mature form of 239 amino acids. Both recombinant caldecrins showed the same chymotrypsin-type protease activity and hypocalcemic activity. The hypocalcemic activity of both remained intact even after treatment with PMSF to abolish their protease activity. These results suggest that human caldecrin possesses hypocalcemic activity that has no connection with its protease activity.
Similar articles
-
Caldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and function.World J Biol Chem. 2015 Nov 26;6(4):358-65. doi: 10.4331/wjbc.v6.i4.358. World J Biol Chem. 2015. PMID: 26629319 Free PMC article. Review.
-
Caldecrin is a novel-type serine protease expressed in pancreas, but its homologue, elastase IV, is an artifact during cloning derived from caldecrin gene.J Biochem. 1998 Mar;123(3):546-54. doi: 10.1093/oxfordjournals.jbchem.a021971. J Biochem. 1998. PMID: 9538241
-
Molecular cloning and expression of serum calcium-decreasing factor (caldecrin).J Biol Chem. 1995 Dec 22;270(51):30315-21. doi: 10.1074/jbc.270.51.30315. J Biol Chem. 1995. PMID: 8530454
-
Determination of amino acid sequence responsible for suppression of bone resorption by serum calcium-decreasing factor (caldecrin).FEBS Lett. 2001 Nov 23;508(3):454-8. doi: 10.1016/s0014-5793(01)03107-6. FEBS Lett. 2001. PMID: 11728471
-
Rat brain expresses serum calcium-decreasing factor (caldecrin).Neurosci Lett. 2002 Jan 4;317(1):17-20. doi: 10.1016/s0304-3940(01)02409-0. Neurosci Lett. 2002. PMID: 11750986
Cited by
-
Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.J Biol Chem. 2010 Aug 13;285(33):25448-57. doi: 10.1074/jbc.M109.068742. Epub 2010 Jun 14. J Biol Chem. 2010. PMID: 20547767 Free PMC article.
-
Arg236 in human chymotrypsin B2 (CTRB2) is a key determinant of high enzyme activity, trypsinogen degradation capacity, and protection against pancreatitis.Biochim Biophys Acta Proteins Proteom. 2022 Sep 1;1870(9):140831. doi: 10.1016/j.bbapap.2022.140831. Epub 2022 Aug 5. Biochim Biophys Acta Proteins Proteom. 2022. PMID: 35934298 Free PMC article.
-
Human pancreatic digestive enzymes.Dig Dis Sci. 2007 Jan;52(1):1-17. doi: 10.1007/s10620-006-9589-z. Epub 2007 Jan 5. Dig Dis Sci. 2007. PMID: 17205399 Review.
-
Caldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and function.World J Biol Chem. 2015 Nov 26;6(4):358-65. doi: 10.4331/wjbc.v6.i4.358. World J Biol Chem. 2015. PMID: 26629319 Free PMC article. Review.
-
The High-Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin-Like Protease: Gln192 and Lys218 Are Key Determinants.Proteins. 2025 Feb;93(2):543-554. doi: 10.1002/prot.26750. Epub 2024 Sep 20. Proteins. 2025. PMID: 39301701 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases